City of Hope (T Cell Manufacturing) vs Minaris Advanced Therapies: CDMO Comparison

How does City of Hope (T Cell Manufacturing) compare to Minaris Advanced Therapies?

As of Aug 2026, City of Hope (T Cell Manufacturing): 3 FDA inspections (including 2 NAI, 1 VAI and 0 OAI). Signal Score 84. Minaris Advanced Therapies: 3 FDA inspections (including 2 NAI, 1 VAI and 0 OAI), 2 EMA/MHRA GMP certificates. Signal Score 83.1. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.

Side-by-side comparison of City of Hope (T Cell Manufacturing) and Minaris Advanced Therapies on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Duarte, CA
Signal Score
84/100
Quality (FDA + GMP)
97/100
FDA inspections
3
— NAI / VAI / OAI
2 / 1 / 0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
215
Capacity
—
Modalities
CAR-T, Cell Therapy
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score
83/100
Quality (FDA + GMP)
99/100
FDA inspections
3
— NAI / VAI / OAI
2 / 1 / 0
FDA warning letters
0
EMA GMP certificates (active)
2
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
0
Capacity
Limited
Modalities
CAR-T, Cell Therapy

Key differences

  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • Minaris Advanced Therapies holds 2 active EMA GMP certificates; City of Hope (T Cell Manufacturing) does not appear in EudraGMDP.
  • City of Hope (T Cell Manufacturing) appears as a manufacturing partner on more matched clinical programs (215 vs 0) — a broader sponsor book.

Across the cross-modality scorecard, City of Hope (T Cell Manufacturing) carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.

Frequently asked: City of Hope (T Cell Manufacturing) vs Minaris Advanced Therapies

How does City of Hope (T Cell Manufacturing) compare to Minaris Advanced Therapies?

On CDMO Signal's composite Signal Score, City of Hope (T Cell Manufacturing) is 84/100 and Minaris Advanced Therapies is 83/100; City of Hope (T Cell Manufacturing) has 3 FDA inspections on record vs 3 for Minaris Advanced Therapies; European coverage is 0 active EMA+MHRA certificates for City of Hope (T Cell Manufacturing) vs 2 for Minaris Advanced Therapies. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.

Which has the stronger FDA inspection record, City of Hope (T Cell Manufacturing) or Minaris Advanced Therapies?

Both City of Hope (T Cell Manufacturing) and Minaris Advanced Therapies maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. City of Hope (T Cell Manufacturing) has 3 FDA inspections on record; Minaris Advanced Therapies has 3.

How do City of Hope (T Cell Manufacturing) and Minaris Advanced Therapies compare on European GMP coverage?

City of Hope (T Cell Manufacturing) holds 0 active EMA GMP certificates and 0 MHRA / UK certificates. Minaris Advanced Therapies holds 2 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is more active in clinical-stage manufacturing — City of Hope (T Cell Manufacturing) or Minaris Advanced Therapies?

City of Hope (T Cell Manufacturing) is matched to 215 ClinicalTrials.gov records as a manufacturing partner; Minaris Advanced Therapies is matched to 0. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.

What does the Signal Score gap mean in practice?

City of Hope (T Cell Manufacturing) carries a Signal Score of 84/100 and Minaris Advanced Therapies carries 83/100 — essentially tied for City of Hope (T Cell Manufacturing). The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating City of Hope (T Cell Manufacturing) and Minaris Advanced Therapies for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.